Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a study of TRC150094 in insulin sensitivity for men with increased cardiometabolic risk
NL-OMON36735Phase 2Recruiting
- Sponsor
- Torrent Pharmaceuticals Limited
- Start
- Oct 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omzotirome in cardiometabolic risk (CMR), obesity, insulin resistance (IR), Abdominal adiposity (ABCD), sponsored by Torrent Pharmaceuticals Limited. Started Oct 2011; status: recruiting.
02
Drugs
omzotirome
03
Conditions
cardiometabolic risk (CMR)obesityinsulin resistance (IR)Abdominal adiposity (ABCD)
Beyond the preview
Go deeper on NL-OMON36735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36735.